BMC Biology (Jun 2019)

Inhibiting eukaryotic ribosome biogenesis

  • Dominik Awad,
  • Michael Prattes,
  • Lisa Kofler,
  • Ingrid Rössler,
  • Mathias Loibl,
  • Melanie Pertl,
  • Gertrude Zisser,
  • Heimo Wolinski,
  • Brigitte Pertschy,
  • Helmut Bergler

DOI
https://doi.org/10.1186/s12915-019-0664-2
Journal volume & issue
Vol. 17, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Background Ribosome biogenesis is a central process in every growing cell. In eukaryotes, it requires more than 250 non-ribosomal assembly factors, most of which are essential. Despite this large repertoire of potential targets, only very few chemical inhibitors of ribosome biogenesis are known so far. Such inhibitors are valuable tools to study this highly dynamic process and elucidate mechanistic details of individual maturation steps. Moreover, ribosome biogenesis is of particular importance for fast proliferating cells, suggesting its inhibition could be a valid strategy for treatment of tumors or infections. Results We systematically screened ~ 1000 substances for inhibitory effects on ribosome biogenesis using a microscopy-based screen scoring ribosomal subunit export defects. We identified 128 compounds inhibiting maturation of either the small or the large ribosomal subunit or both. Northern blot analysis demonstrates that these inhibitors cause a broad spectrum of different rRNA processing defects. Conclusions Our findings show that the individual inhibitors affect a wide range of different maturation steps within the ribosome biogenesis pathway. Our results provide for the first time a comprehensive set of inhibitors to study ribosome biogenesis by chemical inhibition of individual maturation steps and establish the process as promising druggable pathway for chemical intervention.